These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 18981483)

  • 1. Summaries for patients. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults.
    Ann Intern Med; 2008 Nov; 149(9):I-36. PubMed ID: 18981483
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.
    Nass R; Pezzoli SS; Oliveri MC; Patrie JT; Harrell FE; Clasey JL; Heymsfield SB; Bach MA; Vance ML; Thorner MO
    Ann Intern Med; 2008 Nov; 149(9):601-11. PubMed ID: 18981485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of growth hormone secretagogues to prevent or treat the effects of aging: not yet ready for prime time.
    Blackman MR
    Ann Intern Med; 2008 Nov; 149(9):677-9. PubMed ID: 18981489
    [No Abstract]   [Full Text] [Related]  

  • 4. Rejuvenation in older adults receiving oral ghrelin.
    Rafael H
    Ann Intern Med; 2009 May; 150(9):653-4; author reply 655. PubMed ID: 19414850
    [No Abstract]   [Full Text] [Related]  

  • 5. Rejuvenation in older adults receiving oral ghrelin.
    Gaugg M
    Ann Intern Med; 2009 May; 150(9):654; author reply 655. PubMed ID: 19414852
    [No Abstract]   [Full Text] [Related]  

  • 6. Rejuvenation in older adults receiving oral ghrelin.
    Webster J
    Ann Intern Med; 2009 May; 150(9):654-5; author reply 655. PubMed ID: 19414853
    [No Abstract]   [Full Text] [Related]  

  • 7. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects.
    Chapman IM; Bach MA; Van Cauter E; Farmer M; Krupa D; Taylor AM; Schilling LM; Cole KY; Skiles EH; Pezzoli SS; Hartman ML; Veldhuis JD; Gormley GJ; Thorner MO
    J Clin Endocrinol Metab; 1996 Dec; 81(12):4249-57. PubMed ID: 8954023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
    Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
    Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of GH replacement in young patients with childhood onset GH deficiency.
    Christiansen JS; Vahl N; Nørrelund H; Jørgensen JO
    Int J Clin Pract Suppl; 2002 May; (126):32-6. PubMed ID: 12090699
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults.
    Chapman IM; Pescovitz OH; Murphy G; Treep T; Cerchio KA; Krupa D; Gertz B; Polvino WJ; Skiles EH; Pezzoli SS; Thorner MO
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3455-63. PubMed ID: 9329386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
    Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
    J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition.
    Vahl N; Møller N; Lauritzen T; Christiansen JS; Jørgensen JO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3612-8. PubMed ID: 9360515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
    Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
    J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status.
    Wittert GA; Chapman IM; Haren MT; Mackintosh S; Coates P; Morley JE
    J Gerontol A Biol Sci Med Sci; 2003 Jul; 58(7):618-25. PubMed ID: 12865477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.
    Garcia JM; Polvino WJ
    Growth Horm IGF Res; 2009 Jun; 19(3):267-73. PubMed ID: 19196529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and experimental effects of growth hormone secretagogues on various organ systems.
    Svensson JA; Bengtsson B
    Horm Res; 1999; 51 Suppl 3():16-20. PubMed ID: 10592439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body Composition and Ectopic Lipid Changes With Biochemical Control of Acromegaly.
    Bredella MA; Schorr M; Dichtel LE; Gerweck AV; Young BJ; Woodmansee WW; Swearingen B; Miller KK
    J Clin Endocrinol Metab; 2017 Nov; 102(11):4218-4225. PubMed ID: 28945897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of ghrelin on insulin secretion and glucose disposal rate in gastrectomized patients.
    Damjanovic SS; Lalic NM; Pesko PM; Petakov MS; Jotic A; Miljic D; Lalic KS; Lukic L; Djurovic M; Djukic VB
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2574-81. PubMed ID: 16621911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children.
    Codner E; Cassorla F; Tiulpakov AN; Mericq MV; Avila A; Pescovitz OH; Svensson J; Cerchio K; Krupa D; Gertz BJ; Murphy G
    Clin Pharmacol Ther; 2001 Jul; 70(1):91-8. PubMed ID: 11452249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.